Download our Perspective

Theradaptive’s Chief Scientific Officer Frank Vizesi provides an overview of the company’s unique protein and how it hopes to disrupt the bone replacement market during an interview with SmartTRAK at the 2025 NASS Biologic Interventions Meeting. To learn more, read our article!